UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported) May 28, 2006
| |
|
|
| Waters Corporation |
| (Exact Name of Registrant as Specified in Its Charter) |
| |
| |
|
|
| Delaware |
| (State or Other Jurisdiction of Incorporation) |
| |
| |
|
|
| 01-14010 |
|
13-3668640 |
| (Commission File Number)
|
|
(IRS Employer Identification No.) |
| |
|
|
| |
|
|
| 34 Maple Street, Milford, Massachusetts |
|
01757 |
| (Address of Principal Executive Offices)
|
|
(Zip Code) |
| |
|
|
| |
|
|
| (508) 478-2000 |
| (Registrant’s Telephone Number, Including Area Code) |
| |
| |
|
|
| N/A |
| (Former Name or Former Address, if Changed Since Last Report) |
| |
Check the appropriate box below if the Form 8-K filing is intended to satisfy the filing obligation
of the registrant under any of the following provisions (see General Instruction A.2 below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
The purpose of this Form 8-K is to provide information regarding products, both new and planned, to
be presented at the American Society of Mass Spectrometry Conference (ASMS). The conference is
scheduled for May 28, 2006 through June 1, 2006 in Seattle, Washington U.S.A. These products are
tools used by scientists in life science, industrial, and academic laboratories in their pursuit of
better methods of treating diseases, monitoring the environment and manufacturing quality
pharmaceuticals, chemicals, plastics, foods, beverages and numerous other products. Detailed
descriptions of these products can be found within press releases posted at the Company’s web site
(www.waters.com). Key products featured in these press releases include:
| |
1. |
|
Waters® Synapt™ High Definition MS™ - A research mass spectrometry instrument
that combines molecular size and molecular shape discrimination with high sensitivity,
accurate mass MS/MS characterization. Applications for this new instrument include
characterizations of proteins and protein complexes for life science and drug discovery
research. |
| |
| |
2. |
|
Waters® ACQUITY™ TQD – A tandem quadrupole mass spectrometry instrument
designed for UPLC- MS/MS applications. The ACQUITY TQD uniquely combines high
performance, compact size, advanced built-in diagnostics and features for convenient
operation for researchers interested in coupling MS/MS detection with high resolution
and rapid analysis AQUITY UPLC™ separations. |
This release contains “forward-looking” statements regarding future results and events, including
statements regarding future growth and customer demand that involve a number of risks and
uncertainties. For this purpose, any statements contained herein that are not statements of
historical fact may be deemed forward-looking statements. Without limiting the foregoing, the
words, “believes”, “anticipates”, “plans”, “expects”, “intends”, “appears”, “estimates”,
“projects”, and similar expressions are intended to identify forward-looking statements. The
forward-looking statements included in this release represent the Company’s estimates or views as
of the date of this release report and should not be relied upon as representing the Company’s
estimates or views as of any date subsequent to the date of this release. The Company specifically
disclaims any obligation to update these forward-looking statements in the future .